HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Moran, J. K. Articles by Blaufox, M. D. Search for Related Content PubMed PubMed Citation Articles by Moran, J. K. Articles by Blaufox, M. D.

Optimization of Urinary FDG Excretion During PET Imaging

Department of Nuclear Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York

Correspondence: For correspondence or reprints contact: Justin K. Moran, PhD, Department of Nuclear Medicine, 1695A Eastchester Rd., Bronx, NY 10461.

ABSTRACT

Accumulation of fluorodeoxyglucose (FDG) activity in the urine interferes with the visualization of pelvic and, sometimes, abdominal abnormalities. Although this is a major problem, there are few data on the physiological variables affecting FDG urinary excretion that are critical to minimizing urinary FDG interference during PET imaging. Methods: The excretion of FDG in urine was determined during 90 min four groups of rats (n = 24) under the following conditions: normal, hydrated, hydrochlorothiazide treated and phlonzin treated. FDG clearance rates were measured in both normal and phlorizin-treated animals and compared with the glomeruler filtration rate measured with ^99mTc-diethylenetriamine pentaacetic acid. We measured FDG excretion in 10 patients who had no known renal disease and were undergoing PET scanning (divided into two groups: hydrated and dehydrated) to relate the animal data to humans. Results: The hydrated and phlorizin-treated animals had the highest excretion of FDG (39.68 ± 5.00 % injected dose (%ID) and 45.64 ± 9.77 %ID, respectively). Animals given the hydrochlorothiazide had the highest urinary volume, but the percentage excreted was comparable with the normal rats. Measurement of the clearance of FDG in animals before and after the administration of phlorizin determined the amount of FDG reabsorbed in the proximal tubules to be 56% ± 9.15%. The hydrated patients had a higher excretion of FDG than dehydrated patients (16.98 ± 1.99 %ID versus 14.27 ± 1.00 %ID, P < 0.021), and the volume of urine voided was significantly higher (P < 0.020). Conclusion: Hydro chlorothiazide increases urine volume without enhancing FDG excretion. The hydration of patients before PET scanning may lead to more FDG reaching the bladder. Reduction of bladder activity by more frequent voiding facilitated by increased urine volume in hydrated patients maybe offset by increased delivery of FDG to the bladder. A preferable means of increasing urinary volume without increasing delivery of FDG to the bladder maybe the use of a diuretic.

Key Words: fluorodeoxyglucose • PET • excretion

This article has been cited by other articles:

				B. R. Landau, C. L. Spring-Robinson, R. F. Muzic Jr., N. Rachdaoui, D. Rubin, M. S. Berridge, W. C. Schumann, V. Chandramouli, T. S. Kern, and F. Ismail-Beigi 6-Fluoro-6-deoxy-D-glucose as a tracer of glucose transport Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E237 - E245. [Abstract] [Full Text] [PDF]

				S. Lopez-Gandul, G. Perez-Moure, J.R. Garcia-Garzon, M. Soler-Peter, M. Simo-Perdigo, and F. Lomena Intravenous Furosemide Injection During 18F-FDG PET Acquisition J. Nucl. Med. Technol., December 1, 2006; 34(4): 228 - 231. [Abstract] [Full Text] [PDF]

				M. A. Blake, A. Singh, B. N. Setty, J. Slattery, M. Kalra, M. M. Maher, D. V. Sahani, A. J. Fischman, and P. R. Mueller Pearls and Pitfalls in Interpretation of Abdominal and Pelvic PET-CT RadioGraphics, September 1, 2006; 26(5): 1335 - 1353. [Abstract] [Full Text] [PDF]

				G. M. Bormans, G. Van Oosterwyck, T. J. de Groot, M. Veyhl, L. Mortelmans, A. M. Verbruggen, and H. Koepsell Synthesis and Biologic Evaluation of 11C-Methyl-D-Glucoside, a Tracer of the Sodium-Dependent Glucose Transporters J. Nucl. Med., July 1, 2003; 44(7): 1075 - 1081. [Abstract] [Full Text] [PDF]

				S. J. Gatley Labeled Glucose Analogs in the Genomic Era J. Nucl. Med., July 1, 2003; 44(7): 1082 - 1086. [Full Text] [PDF]

				A. D. Williams, C. Cousins, W. P. Soutter, M. Mubashar, A. M. Peters, R. Dina, F. Fuchsel, G. A. McIndoe, and N. M. deSouza Detection of Pelvic Lymph Node Metastases in Gynecologic Malignancy: A Comparison of CT, MR Imaging, and Positron Emission Tomography Am. J. Roentgenol., August 1, 2001; 177(2): 343 - 348. [Abstract] [Full Text] [PDF]